Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1930.99% is 39% above its 5-year average of -3157.02%, near the high end of its 5-year range (-14981.93%–0.00%).
119.72% below its 12-month average of -878.84%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1191.48%.
OPERATING MARGIN
-1930.99%
OPERATING MARGIN AVG TTM
-878.84%
OPERATING MARGIN AVG 3Y
-667.58%
OPERATING MARGIN AVG 5Y
-3157.02%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-119.72%
CURRENT VS 3Y AVG
-189.25%
CURRENT VS 5Y AVG
+38.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 507 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Akanda Corp.
Market Cap
$63114.00
Operating Margin
-1930.99%
TTM Avg
-878.84%
3Y Avg
-667.58%
5Y Avg
-3157.02%
Market Cap
$563178.00
Operating Margin
-20757.65%
TTM Avg
-10953.08%
3Y Avg
-5758.86%
5Y Avg
-3862.92%
Market Cap
$693655.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$815044.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-935.37%
5Y Avg
-623.58%
Market Cap
$877747.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-24.80%
Market Cap
$893920.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$897948.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.01M
Operating Margin
-312016.95%
TTM Avg
-156008.48%
3Y Avg
-78004.24%
5Y Avg
-62403.39%
Market Cap
$1.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $63114.00 | -1930.99% | -878.84% | -667.58% | -3157.02% |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | -20757.65% | -10953.08% | -5758.86% | -3862.92% |
| CDT Equity Inc. (CDT)vs › | $693655.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $815044.00 | 0.00% | 0.00% | -935.37% | -623.58% |
| Decoy Therapeutics Inc. (DCOY)vs › | $877747.00 | 0.00% | 0.00% | 0.00% | -24.80% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $897948.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -312016.95% | -156008.48% | -78004.24% | -62403.39% |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.13M | -7.41% | -3.38% | 2.80% | 2.80% |
Gross Margin
-60.5%
Operating Margin
-1931.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1191.48% |
| 2025-12-31 | -1445.03% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | -564.33% |
| 2024-06-30 | -493.25% |
| 2023-12-31 | -554.70% |
| 2023-06-30 | -424.31% |
| 2022-12-31 | -410.01% |
| 2022-06-30 | -14981.93% |
| 2021-12-31 | -10963.61% |
| 2021-06-30 | -3698.58% |
| 2020-12-31 | -218244.89% |
| 2020-06-30 | -59722.82% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
